Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Alnylam's RNAi therapeutic Onpattro for polyneuropathy of hATTR amyloidosis receives first approval

Aug. 13, 2018

Phase III study of JCR Pharmaceuticals' JR-141 for Hunter syndrome begins

Aug. 10, 2018

I-Mab cleared to conduct clinical trial of TJ-103 in China

Aug. 10, 2018

Positive topline data presented from the pivotal phase III SONICS study of Recorlev

Aug. 9, 2018

Phase III study of Estelle oral contraceptive meets primary efficacy endpoint

Aug. 9, 2018

Neuroendocrine stress pathways mediate the adverse health effects of air pollution

Aug. 8, 2018

JCR Pharmaceuticals presents data for JR-141 in mucopolysaccharidosis type II

Aug. 6, 2018

High-fat diet leads to hair loss?

Aug. 6, 2018

Diabetic fat stem cells are good enough

Aug. 3, 2018

Jiangsu Tasly Diyi Pharmaceutical describes SGLT2 inhibitors

Aug. 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...